seed
Stage
1
Investors
About
Tolerance Bio develops therapies that restore, preserve, and manipulate thymus function to improve immune tolerance and extend healthspan.
Explore Tolerance Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.